PD-1-PD-L1 interactions hinder T-cell receptor-mediated cytotoxicity and CD8+ T-cell proliferation, impeding adaptive immune response against cancer cells; this allows cancer cells to escape destruction and evade immune monitoring (39). Here, CD8A is linked to cancer.